Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,064 INR | -1.31% | +0.80% | +49.40% |
Sales 2024 * | 8.45B 101M | Sales 2025 * | 10.78B 129M | Capitalization | 54.71B 656M |
---|---|---|---|---|---|
Net income 2024 * | 908M 10.88M | Net income 2025 * | 1.42B 17.04M | EV / Sales 2024 * | 6.35 x |
Net cash position 2024 * | 1.06B 12.65M | Net cash position 2025 * | 1.2B 14.34M | EV / Sales 2025 * | 4.96 x |
P/E ratio 2024 * |
59.8
x | P/E ratio 2025 * |
38.6
x | Employees | 838 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.03% |
Latest transcript on Orchid Pharma Limited
1 day | -1.31% | ||
1 week | +0.80% | ||
Current month | +1.88% | ||
1 month | -3.78% | ||
3 months | +23.23% | ||
6 months | +129.49% | ||
Current year | +49.40% |
Managers | Title | Age | Since |
---|---|---|---|
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 20-03-30 |
Director of Finance/CFO | - | 20-06-28 | |
Kapil Dayya
CMP | Compliance Officer | - | Dec. 15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 20-03-30 | |
Mridul Dhanuka
BRD | Director/Board Member | 42 | 20-03-30 |
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 20-03-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 1,064 | -1.31% | 15 701 |
24-04-30 | 1,079 | -0.86% | 31,074 |
24-04-29 | 1,088 | +0.34% | 51,640 |
24-04-26 | 1,084 | -0.74% | 63,987 |
24-04-25 | 1,092 | +2.57% | 52,477 |
Delayed Quote NSE India S.E., May 02, 2024 at 01:59 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+49.40% | 655M | |
+33.25% | 699B | |
+28.59% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.81% | 236B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- ORCHPHARMA Stock